Back to MORGAN STANLEY MORGAN STANLEY

NKTRNKTR
5 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in Nektar Therapeutics

MORGAN STANLEY holds 936,560 shares of NKTR (Nektar Therapeutics), worth $65.4M as of 2026-Q2. The position was increased (+42.0% shares). NKTR represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$65.4M

Current Shares

936,560

Total Value Change

+$63.5M

Total Shares Change

+864,421

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
936,560
+42.0%
$65.4M0.0%$69.81
40
2026-Q1
Increased
659,387
+16.4%
$47.4M0.0%$68.11
34
2025-Q4
Decreased
566,421
-39.0%
$23.9M0.0%$41.90
0
2025-Q3
Increased
929,151
+1188.0%
$52.9M0.0%$58.92
47
2025-Q2
New
72,139
-
$1.9M0.0%$25.76
36

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used